Kai M. Schneider
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
When Lipids Silence Immunity: Dendritic Cell Death in MASLD-associated HCC.
Journal: Journal of hepatology
Published: May 26, 2026
Cancer neuroscience in cholangiocarcinoma: from perineural invasion to neuroimmune control.
Journal: Gut
Published: May 13, 2026
Validated Early Detection Metrics Reduce the Population Requiring Liver Fibrosis Screening.
Journal: Gastroenterology
Published: March 09, 2026
Bile acids in cancer: From metabolism to immunomodulation.
Journal: Immunity
Published: February 24, 2026
Renal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic Syndrome.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: February 24, 2026
Alpha-1 Antitrypsin Deficiency Alleles in Non-Cirrhotic Hepatocellular Carcinoma: Insights from a Multicenter French Cohort.
Journal: Journal of clinical and experimental hepatology
Published: January 21, 2026
Elevated low-density lipoprotein cholesterol levels and prostate cancer risk: UK Biobank evidence.
Journal: World journal of urology
Published: November 04, 2025
TERT rs10069690 variant is linked to reduced cholangiocarcinoma incidence but adverse prognosis in patients undergoing resection.
Journal: eGastroenterology
Published: October 30, 2025
Machine learning for population-level risk prediction of future cholangiocarcinoma.
Journal: EBioMedicine
Published: October 29, 2025
Myeloid TET2 tips the balance of neuro-epithelial crosstalk.
Journal: Immunity
Published: October 07, 2025
The future of hepatology: Preventing liver disease together with the public, scientists and artificial intelligence.
Journal: JHEP reports : innovation in hepatology
Published: October 01, 2025
Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study.
Journal: Cancer discovery
Published: July 30, 2025
Last Updated: 09/26/2026